Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
Clinical trial NCT07188103 · RECRUITING
Trial details
- NCT number
- NCT07188103
- Sponsor
- Anhui Provincial Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-06-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.